DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Lisinopril; Seroquel



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Pneumonia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram
    Start date: 2012-03-06
    End date: 2012-03-13

PEG-Intron
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-05-15

PEG-Intron
    Dosage: 0.75 microgram per kilogram, qw
    Start date: 2012-03-20
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-05-07

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-06-05

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-05-07

Other drugs received by patient: Betamethasone Sodium Phosphate; [therapy Unspecified]; Allegra; Allopurinol; Rabeprazole Sodium; Atarax; Meropenem



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-13

Patient:

Reactions: Pneumonia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-07-03

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-05-28

Rebetol
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-06-04

Rebetol
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-15
    End date: 2012-07-03



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-27



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C

Rebetol

Victrelis



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-11

Patient:

Reactions: Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Lisinopril; Seroquel



Possible PEG-Intron side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27

Patient: male

Reactions: Haemorrhoid Operation, Pneumonia, Pain, Pulmonary Thrombosis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-03-09

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-03-09

Victrelis
    Indication: Hepatitis C
    Start date: 2012-04-13



Possible PEG-Intron side effects in 43 year old male

Reported by a physician from Portugal on 2012-06-19

Patient: 43 year old male

Reactions: Pneumonia, Anaemia, Drug Dependence, Septic Shock, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Heroin (Diamorphine)
    Indication: Product Used FOR Unknown Indication

PEG-Intron
    Indication: Product Used FOR Unknown Indication

Rebetol
    Indication: Product Used FOR Unknown Indication

Victrelis
    Indication: Product Used FOR Unknown Indication



Possible PEG-Intron side effects in 70 year old female

Reported by a physician from United States on 2012-06-12

Patient: 70 year old female

Reactions: Renal Failure, Pneumonia, Respiratory Failure, Anaemia, Bacterial Infection, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 mcg;qw;po
    Administration route: Oral
    Indication: Hepatitis C

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-03

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatic Cirrhosis
    Start date: 2011-11-03



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient: female

Reactions: Weight Decreased, Pneumonia, Hepatitis C, Abasia, Fall, Tremor, Concussion, Disease Recurrence, Facial Bones Fracture

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2003-01-01
    End date: 2003-07-01

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-14

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-02-14

Ribavirin
    Indication: Hepatitis C
    Start date: 2003-01-01
    End date: 2003-07-01



Possible PEG-Intron side effects in female

Reported by a physician from United States on 2012-04-27

Patient: female

Reactions: Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Victrelis
    Indication: Hepatitis C



Possible PEG-Intron side effects in 52 year old male

Reported by a consumer/non-health professional from Canada on 2012-04-20

Patient: 52 year old male

Reactions: Anxiety, Thrombosis, Dyspnoea, Pneumonia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Heptovir



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: qw
    Indication: Hepatitis C
    Start date: 2011-07-01

Ribavirin
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02

Patient: 57 year old female

Reactions: Pneumonia, Staphylococcal Infection, Escherichia Infection, Candidiasis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: ;qw;
    Indication: Hepatitis C
    Start date: 2011-07-01

Ribavirin
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Victrelis
    Dosage: ;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-01
    End date: 2012-01-01



Possible PEG-Intron side effects in 64 year old male

Reported by a physician from Spain on 2012-03-23

Patient: 64 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Pneumonia, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-01-13

Ribavirin
    Dosage: 800 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-10

Other drugs received by patient: Propranolol; Amiloride Hydrochloride



Possible PEG-Intron side effects in 52 year old male

Reported by a consumer/non-health professional from Canada on 2012-03-20

Patient: 52 year old male

Reactions: Thrombosis, Anxiety, Pneumonia, Headache, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-12

Patient: 57 year old female

Reactions: Pneumonia, Metabolic Acidosis, Necrosis, Hepatic Failure, Multi-Organ Failure, Renal Failure, Dialysis, Abscess, Pneumonia Staphylococcal, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Boceprevir (Sch-503034)
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30

Ribavirin
    Dosage: 400mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-19
    End date: 2012-01-30



Possible PEG-Intron side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-28

Patient: 55 year old male

Reactions: Pneumonia, Vomiting, RED Blood Cell Count Decreased, Impaired Healing, Haemoptysis, Alopecia, Blood Count Abnormal, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-12-14
    End date: 2012-02-03

PEG-Intron
    Indication: Hepatitis C
    Start date: 2009-12-30
    End date: 2010-04-26

Procrit
    Indication: Product Used FOR Unknown Indication

Rebetol
    Indication: Hepatitis C
    Start date: 2009-12-30
    End date: 2010-04-26

Rebetol
    Indication: Hepatitis C
    Start date: 2011-12-15
    End date: 2012-02-03

Victrelis
    Indication: Hepatitis C
    Start date: 2012-01-12
    End date: 2012-02-03



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-21

Patient: female

Reactions: Pneumonia, Head Injury, Hypotension, Urinary Tract Infection, Abnormal Behaviour, Fall, Idiopathic Pulmonary Fibrosis, Mental Impairment, Insomnia, Feeling Abnormal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-08-26
    End date: 2011-12-24

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-08-26
    End date: 2011-12-24



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15

Patient: female

Reactions: White Blood Cell Count Decreased, Pneumonia, Chest Discomfort, Pulmonary Sarcoidosis, Incorrect Dose Administered, Biopsy Larynx Abnormal, Pyrexia, Staphylococcal Infection, Mental Disorder, Memory Impairment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-01-09

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15

Ribavirin
    Indication: Hepatitis C
    Start date: 2012-01-09

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15

Telaprevir
    Indication: Hepatitis C
    Start date: 2012-01-09



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-13

Patient:

Reactions: Hepatic Encephalopathy, Pneumonia, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09

Patient:

Reactions: Pneumonia, Hepatic Encephalopathy, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Victrelis
    Indication: Hepatitis C



Possible PEG-Intron side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 26 year old male, weighing 69.9 kg (153.7 pounds)

Reactions: Pneumonia, Respiratory Failure, Respiratory Arrest, Infection

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Humira; Fosamax; Atenolol; Adderall 5; Entocort EC; Luvox



Possible PEG-Intron side effects in 61 year old male

Reported by a physician from Hungary on 2012-01-31

Patient: 61 year old male

Reactions: Haemoglobin Decreased, Agranulocytosis, Pneumonia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-09-30

Rebetol
    Dosage: 1200 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-30

Victrelis
    Dosage: 2400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-30



Possible PEG-Intron side effects in female

Reported by a individual with unspecified qualification from United States on 2012-01-26

Patient: female

Reactions: Pneumonia, Staphylococcal Infection, Sarcoidosis, Pharyngitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-01-07
    End date: 2011-08-15



Possible PEG-Intron side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-13

Patient: 26 year old male

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral
    End date: 2011-10-06

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-07-22
    End date: 2011-10-06

Other drugs received by patient: Atenolol; Luvox; Entocort EC; Humira; Adderall Tablets; Vitamins (Unspecified)



Possible PEG-Intron side effects in 44 year old male

Reported by a physician from Germany on 2011-12-05

Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Agitation, Hemiparesis, Loss of Consciousness, Polyneuropathy, Hyperventilation, Haemangioma of Liver, Dialysis, Decubitus Ulcer, Depression, Thrombocytopenia, Renal Failure Acute, Refusal of Treatment by Patient, Pneumonia, Cellulitis, Hypothermia, Hyponatraemia, Perichondritis, Hypophosphataemia, Respiratory Failure, Oedematous Pancreatitis, Withdrawal Syndrome, Normochromic Normocytic Anaemia, Septic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-03-22
    End date: 2011-08-21

Rebetol
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-22



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014